Purchase Order FA864924P0552

Award Date 2/9/24
Potential Completion Date 11/7/25
Potential Value $1.8M
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Herndon, VA 20170, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
84
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
STTR Phase II
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order contract awarded by the Air Force Research Laboratory to Perfusion Medical LLC, a small biotechnology company, for a human clinical trial to assess the safety of the PM-208 anti-shock drug. The $1,799,970.00 contract is part of the Small Business Technology Transfer (STTR) Phase II program and is set aside for small businesses. Perfusion Medical LLC specializes in developing innovative intravenous solutions for acute medical conditions, with a focus on...
The U.S. Air Force Research Laboratory (AFRL) awarded a $74,948.00 Firm Fixed Price Purchase Order to Perfusion Medical LLC, a small business, for the research and development of PEG-20K/8K, a patented intravenous solution to treat hemorrhagic shock. This Small Business Technology Transfer (STTR) Phase I contract supports Perfusion Medical's efforts to commercialize its novel pipeline product, PEG-20K IV solution, which was originally developed by researchers at Virginia Commonwealth University....
The U.S. Air Force Research Laboratory (AFRL) awarded a $74,948.00 Small Business Technology Transfer (STTR) Phase I contract to Perfusion Medical LLC, a biotechnology company, to develop a patented intravenous solution called PEG-20K/8K to treat septic shock. This firm-fixed-price purchase order contract has an ultimate completion date of August 5, 2023. Perfusion Medical LLC is a small business that specializes in developing innovative intravenous solutions for acute medical conditions. This...
The U.S. Air Force Research Laboratory awarded a $74,975 firm fixed price Small Business Innovation Research (SBIR) Phase I purchase order to Perfusion Medical LLC, a biotechnology company, for the research and development of PEG-20K/8K, a patented intravenous solution for the treatment of acute kidney injury, septic shock, and hemorrhagic shock. The contract is set aside for small businesses. Perfusion Medical LLC is commercializing this solution, which was developed by researchers at...
This is a firm fixed-price purchase order awarded to 410 Medical, Inc., a small business medical device manufacturer, by the Air Force Research Laboratory (AFRL) under the Small Business Innovation Research (SBIR) program. The contract is for the development and testing of an ultra-lightweight rapid infuser to be integrated with fluid warmers, with a ceiling value of $1,249,578.00. The contract has a total small business set-aside designation and a period of performance ending on May 29, 2026....
The U.S. Air Force Research Laboratory (AFRL) awarded a $1,245,650.00 SBIR Phase II contract to Nanoguard Medical Solutions, LLC, a small disadvantaged business, for the development of a "SAVING LIVES IN COMBAT - A REVOLUTIONARY NANOFIBER WOUND CARE" product. The contract is a firm fixed-price purchase order with a period of performance through February 17, 2026. This SBIR Phase II action is part of the AFRL's efforts to support the development of innovative technologies for defense...
This is a $149,999 Small Business Technology Transfer (STTR) Phase I contract awarded by the Air Force Research Laboratory (AFRL) to Technology Holding LLC, a small, for-profit limited liability company. The contract is for the development of "Biomimetic Material Solutions for the Stabilization of Labile Reagents," which aims to leverage innovative biotechnology and materials science to address national security needs. Technology Holding LLC is the prime contractor on this...
This is a $1,499,987.16 Firm Fixed Price Definitive Contract awarded by the U.S. Army Medical Command (MEDCOM) to Cytosorbents Medical Inc., a small business manufacturer, under the Small Business Innovation Research (SBIR) program. The contract is for medical research and development to investigate a potassium adsorber for treating hyperkalemia resulting from traumatic injury and acute kidney injury in austere environments. This is a Phase II SBIR action with a completion date of February 20,...
The U.S. Air Force Research Laboratory awarded a $749,886 Small Business Innovation Research (SBIR) Phase II contract to 410 Medical, Inc. to develop a "New Handheld Rapid Infuser Ultra for Warfighter Resuscitation at the Point of Injury." 410 Medical is a medical device manufacturer that specializes in products for urgent trauma care and rapid resuscitation, including the LifeFlow hand-operated infuser. The Air Force has awarded multiple SBIR, STTR, and purchase order contracts to 410...
This is a $249,923 firm fixed-price purchase order awarded by the Air Force Research Laboratory to Bloodstone Division LLC, a service-disabled veteran-owned small business based in Tampa, Florida. The contract is for the development of COVID-19 related medical products, including thermal insulation, vibration mitigation, and pressure injury reduction solutions for casualties. This contract is a Small Business Innovation Research (SBIR) Phase II award, indicating it is a follow-on to prior...

This is a $1,799,322.00 Firm Fixed Price Purchase Order awarded by the Air Force Research Laboratory (AFRL) to Perfusion Medical LLC, a small biotechnology company, for research and development of an optimal dosing and formulation of the drug PM-208 (PEG-20K/8K) for use in Air Force field operations. This is a Small Business Technology Transfer (STTR) Phase II contract with a completion date of November 7, 2025. Perfusion Medical specializes in developing innovative intravenous solutions for acute medical conditions, and this contract focuses on advancing their PEG-20K/8K therapeutic, which aims to treat critical emergencies like septic shock, hemorrhagic shock, and acute kidney injury. The company has received previous STTR and Small Business Innovation Research (SBIR) awards from AFRL, as well as a significant grant from the National Institute of General Medical Sciences for related research into using the PEG-20K solution to address sepsis.

Generated 6/19/25, 9:49 AM